Top Pharma Companies in India by Market Cap

HealthCare Global Enterprises has informed that 28th Annual General Meeting (AGM) of the Members of the Company was held on Friday, September 18, 2026, at 5.00 PM (IST) through Video Conferencing (‘VC’)/ Other Audio Visual Means (‘OAVM’) in compliance with the General Circulars issued by the Ministry of Corporate Affairs (‘MCA’) and circulars issued by the Securities and Exchange Board of India (‘SEBI’) and as per the applicable provisions of the Companies Act, 2013 and Listing Regulations. All the resolutions set out in the AGM notice have been approved by the Members with requisite majority. In this regard, it has enclosed the following: (i) Consolidated report dated September 18, 2026, of the Scrutinizer signed by Pradeep B Kulkarni, Partner, V. Sreedharan & Associates, Company Secretaries, on e-voting and voting at the Annual General Meeting, in compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules 2014, annexed as Annexure-A and (ii) Voting results in compliance with Regulation 44(3) of the Listing Regulations read with SEBI Circular, annexed as Annexure- B. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/. 

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific has informed that he Nomination and Remuneration Committee of the Company vide resolution passed by circulation on September 18, 2026, has approved the allotment of 11,07,309 equity shares of face value Rs. 2/- each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as detailed below: a. 9,26,333 equity shares at an exercise price of Rs. 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 1,80,976 equity shares at an exercise price of Rs.101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Consequent to the aforesaid allotment, the issued and paid-up equity share capital of the Company has increased from Rs. 88,10,40,722/- consisting of 44,05,20,361 Equity Shares of Rs. 2 each to Rs. 88,32,55,340/-, comprising of 44,16,27,670 Equity Shares of Rs. 2 each.

The above information is a part of company’s filings submitted to BSE.